Humana Inc vs Orion Office REIT Inc — how do they compare? Humana Inc trades at $445 (market cap $47.61B), while Orion Office REIT Inc trades at $2.19 (market cap $129.49M). The key difference: Humana Inc is far larger — about 367.7× Orion Office REIT Inc's market cap, and Orion Office REIT Inc pays the higher dividend (3.52%). Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and Orion Office REIT Inc for 33 Days on average.
| HUM | ONL | |
|---|---|---|
Market Cap | $47.61B | $129.49M |
Volume | 1,827,332 | 226,975 |
Sector | Health | Real Estate |
52-Week High | $409.85 | $3.00 |
52-Week Low | $163.67 | $1.93 |
Typical Hold Time | 53 Days | 33 Days |
Enterprise Value | $54.97B | $546.42M |
Dividend Yield | 0.89% | 3.52% |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 4.24% today, but maintains a bullish technical outlook with strong institutional support. The stock shows mixed fundamentals with revenue growth to $129.66B in 2025 but declining profit margins at 0.88%. Recent analyst upgrades, including Barclays' $515 target on September 25, 2026, highlight optimism despite ongoing Medicare Advantage plan adjustments affecting member transitions.
Investment outlook remains cautiously optimistic with a consensus price target of $432.63 offering 12% upside. Risks include margin compression, regulatory scrutiny from Medicare billing practices, and competitive pressures in managed care. The company's strong cash position of $20.44B and consistent dividend payments provide stability amid enrollment volatility.
Orion Office REIT (ONL) trades at $2.27, down 2.58% today, with a bearish technical signal despite recent earnings beat. The company shows deteriorating fundamentals with revenue declining from $208M in 2022 to $148M in 2025 and net losses widening to -$139M. Analyst sentiment is divided with 50% buy and 50% hold ratings, while technical indicators show mixed signals with moving averages bearish but oscillators bullish.
ONL presents a high-risk opportunity with deep value metrics (P/S 0.9, P/B 0.2) but significant operational challenges. The office REIT faces structural headwinds with negative profitability and declining revenue, though strategic repositioning efforts and potential AI-driven office demand could offer upside. Investors should weigh the attractive valuation against persistent losses and office sector challenges.
Trailing returns across standard periods
Latest headlines on both assets
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →Orion Office REIT Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased primarily on a single-tenant net lease basis to creditworthy clients.
Read more on ONL →